scispace - formally typeset
H

Hassan Fouayzi

Researcher at University of Massachusetts Medical School

Publications -  44
Citations -  2819

Hassan Fouayzi is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Population & Medicare Part D. The author has an hindex of 19, co-authored 41 publications receiving 2122 citations. Previous affiliations of Hassan Fouayzi include Kaiser Permanente.

Papers
More filters
Journal ArticleDOI

Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults.

TL;DR: This national survey explores factors associated with vaccine hesitancy and suggests that multipronged efforts will be needed to increase acceptance of a coronavirus disease 2019 vaccine.
Journal ArticleDOI

Comparison of drug adherence rates among patients with seven different medical conditions.

TL;DR: To compare drug adherence rates among patients with gout, hypercholesterolemia, hypertension, hypothyroidism, osteoporosis, seizure disorders, and type 2 diabetes mellitus by using a standardized approach.
Journal ArticleDOI

Adherence with urate-lowering therapies for the treatment of gout

TL;DR: Non-adherence amongst gout patients initiating ULDs is exceedingly common, particularly in younger patients with less comorbidity and no provider visits for gout prior to ULD initiation, and providers should be aware of the magnitude of non-adherentness.
Journal ArticleDOI

Building a virtual cancer research organization.

TL;DR: The CRN research management Web site and associated standardized data files and procedures represent a quasi-public resource, and the CRN stands ready to collaborate with researchers from outside institutions in developing and conducting innovative public domain research.
Journal ArticleDOI

Validity of gout diagnoses in administrative data.

TL;DR: Use of administrative data alone in epidemiologic and health services research on gout research may lead to misclassification and medical record reviews for validation of claims data may provide an inadequate gold standard to confirm gout diagnoses.